🔗 Permalink

Inventor profile of:

Damon Smith

City:

Saint-Laurent

Country:

Canada

Published Applications:

Last publication date:

2018-07-12

Top Assignees for applications by Damon Smith

The entities that hold a legal rights for patent applications filed by inventor Smith Damon:

PALADIN LABS EUROPE LIMITED 13 Dublin, Ireland
Paladin Labs Inc. 8 Montreal, Canada
PALADIN LABS (BARBADOS) INC. 7 Hastings, Christ Church, Barbados
Paladin Labs (Barbados) Inc. 7 Hastings, Barbados
Paladin Labs Inc. 6 Montreal (Quebec), Canada
Angelini Pharma Inc. 3 Gaithersburg, MD United States
PALADIN LABS INC. 2 Montreal, QC Canada
Labopharm Europe Limited 1 Dublin, Ireland
Labopharm (Barbados) Limited 1 St. Michael, Barbados
Angelini Labopharm, LLC 1 Princeton, NJ United States
Labopharm, Inc. 1 Quebec, Canada
Labopharm, Inc. 1 Laval, Canada

Recent patent applications by Smith Damon

Damon Smith from Saint-Laurent, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-07-12

US20180193466A1

Human necessities

STARCH-BASED MICROPARTICLES FOR THE RELEASE OF AGENTS DISPOSED THEREIN

#2 | 2018-07-05

US20180185292A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#3 | 2018-07-05

US20180185289A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#4 | 2018-05-24

US20180140706A1

Human necessities

Solid formulations of liquid biologically active agents

#5 | 2016-12-22

US20160367483A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#6 | 2016-12-15

US20160361262A1

Human necessities

SUSTAINED DRUG RELEASE COMPOSITION

#7 | 2016-10-27

US20160310432A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#8 | 2016-07-07

US20160193341A1

Human necessities

SOLID FORMULATIONS OF LIQUID BIOLOGICALLY ACTIVE AGENTS

#9 | 2015-10-29

US20150306041A1

Human necessities

SUSTAINED DRUG RELEASE COMPOSITION

#10 | 2015-10-01

US20150272890A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#11 | 2015-10-01

US20150272888A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#12 | 2014-10-30

US20140323587A1

Human necessities

SOLID FORMULATIONS OF LIQUID BIOLOGICALLY ACTIVE AGENTS

#13 | 2014-10-02

US20140294955A1

Human necessities

Misuse preventative, controlled release formulation

#14 | 2014-10-02

US20140294954A1

Human necessities

Misuse preventative, controlled release formulation

#15 | 2014-09-04

US20140248346A1

Human necessities

Misuse preventative, controlled release formulation

#16 | 2014-07-24

US20140206704A1

Human necessities

STARCH-BASED MICROPARTICLES FOR THE RELEASE OF AGENTS DISPOSED THEREIN

#17 | 2014-07-10

US20140193494A1

Human necessities

Misuse preventative, controlled release formulation

#18 | 2014-01-02

US20140004191A1

Human necessities

Misuse preventative, controlled release formulation

#19 | 2013-12-26

US20130344142A1

Human necessities

Misuse preventative, controlled release formulation

#20 | 2013-02-14

US20130039864A1

Human necessities

Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof

#21 | 2012-11-15

US20120289606A1

Human necessities

Solid Formulations of Liquid Biologically Active Agents

#22 | 2011-02-10

US20110033537A1

Human necessities

Sustained drug release composition

#23 | 2011-02-03

US20110027370A1

Human necessities

Sustained drug release composition

#24 | 2011-01-27

US20110021535A1

Human necessities

Trazodone composition for once a day administration

#25 | 2011-01-20

US20110015205A1

Human necessities

Trazodone Composition for Once a Day Administration

#26 | 2010-09-23

US20100239662A1

Human necessities

Misuse preventative, controlled release formulation

#27 | 2010-06-17

US20100151022A9

Human necessities

Controlled-release compositions

#28 | 2010-03-18

US20100068268A1

Human necessities

STARCH-BASED MICROPARTICLES FOR THE RELEASE OF AGENTS DISPOSED THEREIN

#29 | 2009-10-15

US20090258071A1

Human necessities

COMPOSITIONS AND METHODS FOR PH TARGETED DRUG DELIVERY

#30 | 2009-07-09

US20090175937A1

Human necessities

Misuse preventative, controlled release formulation

#31 | 2009-05-21

US20090130183A1

Human necessities

Bilayer composition for the sustained release of acetaminophen and tramadol

#32 | 2007-06-07

US20070128275A1

Human necessities

Trazodone composition for once a day administration

#33 | 2007-06-07

US20070128269A1

Human necessities

Sustained drug release compositions

#34 | 2006-10-26

US20060240107A1

Human necessities

Controlled-release compositions

InventorID:

89036 ⎘